Avricore Health (AVCRF) Total Non-Current Liabilities (2010 - 2025)
Avricore Health (AVCRF) posted quarterly Total Non-Current Liabilities of $326363.9 for Q4 2025, down 63.13% sequentially from $885281.6 in Q4 2020.
Avricore Health (AVCRF) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends
Avricore Health has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $326363.9 for Q4 2025.
- In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $326363.9; the TTM figure through Dec 2025 stood at $326363.9 (changed N/A YoY), while the FY2025 annual figure was $325742.7, changed N/A from the prior year.
- Total Non-Current Liabilities eased to $326363.9 in Q4 2025, from $885281.6 in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for AVCRF reached as high as $326363.9 in Q4 2025 and fell as low as $326363.9 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Avricore Health | - | - | - | 326,363.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 326,363.89 |
| Dec 31, 2020 | 885,281.57 |
| Dec 31, 2019 | 494,237.38 |
| Dec 31, 2018 | 238,073.69 |
| Dec 31, 2017 | 237,787.01 |
| Dec 31, 2016 | 267,897.44 |
| Jun 30, 2010 | 231,586.53 |